Summary
Cordis Corporation (Cordis), a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surgery. The company’s cardiology portfolio comprises sheaths, diagnostic guidewires, diagnostic catheters, steerable guidewires and PTCA Balloons. It also provides products such as access accessories, vena cava filters, crossing devices, guiding catheters, PTA balloons, self expanding stents, specialty balloons, hydrophilic nitinol guidewire, balloon expandable stents, transhepatic biliary stent, carotid stent system and vascular closure devices among others. The company has operations in Japan, Canada, Europe, Middle East and Africa. Cordis is headquartered in Fremont, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cordis Corporation
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
- Cordis Corporation Company Snapshot
- Cordis Corporation Company Overview
- Cordis Corporation Pipeline Products and Clinical Trials Overview
- Cordis Corporation – Pipeline Analysis Overview
- Key Facts
- Cordis Corporation - Major Products and Services
- Cordis Corporation Pipeline Products by Development Stage
- Cordis Corporation Clinical Trials by Trial Status
- Cordis Corporation Pipeline Products Overview
- Corio Pimecrolimus-eluting Stent
- Corio Pimecrolimus-eluting Stent Product Overview
- CYPHER ELITE
- CYPHER ELITE Product Overview
- Cypher Neo
- Cypher Neo Product Overview
- ELITECROSS Support Catheter
- ELITECROSS Support Catheter Product Overview
- EP Contact Force Sensing Catheter Enabled By CARTO 3
- EP Contact Force Sensing Catheter Enabled By CARTO 3 Product Overview
- EP Lesion Assessment Device
- EP Lesion Assessment Device Product Overview
- FlexStent Femoropopliteal Self Expanding Stent System - SFA
- FlexStent Femoropopliteal Self Expanding Stent System - SFA Product Overview
- FlexStent Femoropopliteal Self Expanding Stent System - SFA Clinical Trial
- FlexStent Self Expanding Below-The-Knee Venous Stent System
- FlexStent Self Expanding Below-The-Knee Venous Stent System Product Overview
- FlexStent Self Expanding Venous Stent System
- FlexStent Self Expanding Venous Stent System Product Overview
- Flow Diverter
- Flow Diverter Product Overview
- INCRAFT AAA Stent Graft
- INCRAFT AAA Stent Graft Product Overview
- INCRAFT AAA Stent Graft Clinical Trial
- NEVO Sirolimus-Eluting Coronary Stent
- NEVO Sirolimus-Eluting Coronary Stent Product Overview
- Next Generation Coronary Stent
- Next Generation Coronary Stent Product Overview
- Next Generation EMPIRA PTCA Balloon
- Next Generation EMPIRA PTCA Balloon Product Overview
- NOGA Guided Myostar Injection Catheter
- NOGA Guided Myostar Injection Catheter Product Overview
- NOGA Guided Myostar Injection Catheter Clinical Trial
- SeptRx PFO
- SeptRx PFO Product Overview
- SymBio Pimecrolimus/Paclitaxel-eluting Stent
- SymBio Pimecrolimus/Paclitaxel-eluting Stent Product Overview
- Tibial SE FlexStent
- Tibial SE FlexStent Product Overview
- Cordis Corporation - Key Competitors
- Cordis Corporation - Key Employees
- Cordis Corporation - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Cordis Corporation, Recent Developments
- May 12, 2016: Biosensors Announces Strategic Agreement With Cardinal Health
- Mar 04, 2016: Palmaz Scientific Announces Chapter 11 Filing; Seeks Prospective Buyers for Its Breakthrough Technology
- Nov 19, 2015: Strong Results Reported for the Cordis INCRAFT AAA Stent Graft System with New Four-Year Data from the INNOVATION Trial
- Oct 09, 2015: Cardinal Health and Cordis Debut Combined Offering of Cardiovascular Product Advances at TCT 2015
- Jun 08, 2015: Cordis Expands Crossing Portfolio by the launch of OUTBACK Elite Re-Entry Catheter for the Treatment of Chronic Total Occlusions
- Jun 08, 2015: Cordis Expands Crossing Portfolio by the Launch of ELITECROSS Support Catheter for the Treatment of Chronic Total Occlusions
- Jan 05, 2015: Acacia Subsidiary Enters into Settlement and Patent License Agreement with Cordis
- Nov 19, 2014: Cordis Leads With Strong Podium Presence At VEITH 2014 With Presentation Of S.M.A.R.T. Stent Data
- Nov 19, 2014: Cordis Leads With Strong Podium Presence At VEITH 2014 With First-Ever Presentation Of Three-Year INCRAFT System Data
- Sep 10, 2014: Cordis Launches INCRAFT AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Cordis Corporation Pipeline Products and Clinical Trials Overview
- Cordis Corporation Pipeline Products by Equipment Type
- Cordis Corporation Pipeline Products by Indication
- Cordis Corporation Clinical Trials by Trial Status
- Cordis Corporation, Key Facts
- Cordis Corporation, Major Products and Services
- Cordis Corporation Number of Pipeline Products by Development Stage
- Cordis Corporation Pipeline Products Summary by Development Stage
- Cordis Corporation Clinical Trials by Trial Status
- Cordis Corporation Clinical Trials Summary
- Corio Pimecrolimus-eluting Stent - Product Status
- Corio Pimecrolimus-eluting Stent - Product Description
- CYPHER ELITE - Product Status
- CYPHER ELITE - Product Description
- Cypher Neo - Product Status
- Cypher Neo - Product Description
- ELITECROSS Support Catheter - Product Status
- ELITECROSS Support Catheter - Product Description
- EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status
- EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description
- EP Lesion Assessment Device - Product Status
- EP Lesion Assessment Device - Product Description
- FlexStent Femoropopliteal Self Expanding Stent System - SFA - Product Status
- FlexStent Femoropopliteal Self Expanding Stent System - SFA - Product Description
- FlexStent Femoropopliteal Self Expanding Stent System - SFA - Evaluation of Safety and Efficacy of the FlexStent Femoropopliteal Self-expanding Stent System Study
- FlexStent Self Expanding Below-The-Knee Venous Stent System - Product Status
- FlexStent Self Expanding Below-The-Knee Venous Stent System - Product Description
- FlexStent Self Expanding Venous Stent System - Product Status
- FlexStent Self Expanding Venous Stent System - Product Description
- Flow Diverter - Product Status
- Flow Diverter - Product Description
- INCRAFT AAA Stent Graft - Product Status
- INCRAFT AAA Stent Graft - Product Description
- INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects with Abdominal Aortic Aneurysms (INSPIRATION)
- INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms
- INCRAFT AAA Stent Graft - Compassionate Use of the Incraft AAA Stent Graft System
- NEVO Sirolimus-Eluting Coronary Stent - Product Status
- NEVO Sirolimus-Eluting Coronary Stent - Product Description
- Next Generation Coronary Stent - Product Status
- Next Generation Coronary Stent - Product Description
- Next Generation EMPIRA PTCA Balloon - Product Status
- Next Generation EMPIRA PTCA Balloon - Product Description
- NOGA Guided Myostar Injection Catheter - Product Status
- NOGA Guided Myostar Injection Catheter - Product Description
- NOGA Guided Myostar Injection Catheter - A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction
- SeptRx PFO - Product Status
- SeptRx PFO - Product Description
- SymBio Pimecrolimus/Paclitaxel-eluting Stent - Product Status
- SymBio Pimecrolimus/Paclitaxel-eluting Stent - Product Description
- Tibial SE FlexStent - Product Status
- Tibial SE FlexStent - Product Description
- Cordis Corporation, Key Employees
- Cordis Corporation, Other Locations
- List of Figures
- Cordis Corporation Pipeline Products by Equipment Type 9
- Cordis Corporation Pipeline Products by Development Stage
- Cordis Corporation Clinical Trials by Trial Status